Gemcitabine, Doxorubicin and Paclitaxel (GAT) as Neoadjuvant Treatment of Breast Cancer Patients

NCT00128856 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

46

Enrollment

OTHER

Sponsor class

Conditions

Breast Cancer

Interventions

DRUG: Gemcitabine
DRUG: Adriamycine
DRUG: Paclitaxel

Sponsor

Spanish Breast Cancer Research Group

Collaborators

[object Object]
[object Object]